Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1155/2015/651580 http://scihub22266oqcxt.onion/10.1155/2015/651580 C4469842!4469842!26146569     free     free     free       Prostate+Cancer 2015 ; 2015 (ä): ä Nephropedia Template TP {{tp|p=26146569|t=2015. Cellular Plasticity in Prostate Cancer Bone Metastasis |pdf=|usr=}}{{26146569}} gab.com Text Cellular Plasticity in Prostate Cancer Bone Metastasis JO: Prostate Cancer http://www.kidney.de/pget.php?&tw=1&pmid=26146569 #FOAvip Purpose. Experimental data suggest that tumour cells can reversibly transition between epithelial and mesenchymal states (EMT and MET), a phenomenon known as cellular plasticity. The aim of this review was to appraise the clinical evidence for the role of cellular plasticity in prostate cancer (PC) bone metastasis. Methods. An electronic search was performed using PubMed for studies that have examined the differential expression of epithelial, mesenchymal, and stem cell markers in human PC bone metastasis tissues. Results. The review included nineteen studies. More than 60% of the studies used ?20 bone metastasis samples, and there were several sources of heterogeneity between studies. Overall, most stem cell markers analysed, except for CXCR4, were positively expressed in bone metastasis tissues, while the expression of EMT and MET markers was heterogeneous between and within samples. Several EMT and stemness markers that are involved in osteomimicry, such as Notch, Met receptor, and Wnt/? pathway, were highly expressed in bone metastases. Conclusions. Clinical findings support the role of cellular plasticity in PC bone metastasis and suggest that epithelial and mesenchymal states cannot be taken in isolation when targeting PC bone metastasis. The paper also highlights several challenges in the clinical detection of cellular plasticity. Twit Text FOAVip Cellular Plasticity in Prostate Cancer Bone Metastasis ????Prostate Cancer http://www.kidney.de/pget.php?&tw=1&pmid=26146569 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26146569 #FOAvip English Wikipedia <ref>{{Cite pmid|26146569}}</ref> Cellular Plasticity in Prostate Cancer Bone Metastasis #MMPMID26146569 Jadaan DY; Jadaan MM; McCabe JP Prostate Cancer 2015[]; 2015 (ä): ä PMID26146569show ga Purpose. Experimental data suggest that tumour cells can reversibly transition between epithelial and mesenchymal states (EMT and MET), a phenomenon known as cellular plasticity. The aim of this review was to appraise the clinical evidence for the role of cellular plasticity in prostate cancer (PC) bone metastasis. Methods. An electronic search was performed using PubMed for studies that have examined the differential expression of epithelial, mesenchymal, and stem cell markers in human PC bone metastasis tissues. Results. The review included nineteen studies. More than 60% of the studies used ?20 bone metastasis samples, and there were several sources of heterogeneity between studies. Overall, most stem cell markers analysed, except for CXCR4, were positively expressed in bone metastasis tissues, while the expression of EMT and MET markers was heterogeneous between and within samples. Several EMT and stemness markers that are involved in osteomimicry, such as Notch, Met receptor, and Wnt/? pathway, were highly expressed in bone metastases. Conclusions. Clinical findings support the role of cellular plasticity in PC bone metastasis and suggest that epithelial and mesenchymal states cannot be taken in isolation when targeting PC bone metastasis. The paper also highlights several challenges in the clinical detection of cellular plasticity. äCellular Plasticity in Prostate Cancer Bone Metastasis (epmc).pdf DeepDyve Pubget Overpricing